Kylie Minogue kept her second breast cancer diagnosis to herself for five years before revealing it in a new Netflix documentary. The 57-year-old said she did not feel she owed the world the news and that at the time she could barely cope with it herself.
Minogue first battled breast cancer in 2005, when she was 36, after what she said was an initial misdiagnosis. Her diagnosis was made public and prompted a 101 per cent increase in women booking breast screening, a measure of how far her case reached beyond pop music and into public health. After a partial mastectomy, chemotherapy and radiotherapy, she was pronounced cancer-free in 2006.
Then, in 2021, breast cancer was detected again at a routine check-up. Minogue said, “I don’t feel obliged to tell the world,” and added, “And actually, I couldn’t at the time because I was just a shell of a person.” She later said, “Thankfully, I got through it. Again. And all is well. Hey, who knows what’s around the corner?”
The timing of her disclosure matters because the science around recurrence is moving closer to the experience many patients already know. Up to 30 per cent of women diagnosed with breast cancer experience a relapse, and about one in seven women in Australia will develop the disease. The most common form is estrogen receptor-positive breast cancer, which accounts for 70 to 80 per cent of cases, and it is often the type that can return years later.
A study published in Nature Communications helps explain why. Some cancer cells can lie dormant and later wake up again, causing metastasis. But the new research found that other cells do not go dormant at all; they simply slow down so much that standard treatments, which mainly target fast-growing cells, may leave them behind. Those cells can stay below the limit of detection on scans until enough accumulate for recurrence to be found.
Liz Caldon, who was quoted in the research discussion, said: “They remain beyond the limit of detection of things like scans and then it’s only when you get enough of them there that the recurrence is finally detected,” The result, especially when ER-positive breast cancer comes back, can be a disease that is harder to treat and may require long-term therapy.
Minogue has not publicly said what type of cancer she had, but her story shows the quiet reality behind a public triumph. The first diagnosis may have saved lives by sending women to screening in greater numbers. The second, hidden for years, now lands in a moment when doctors are still learning why some cancers wait, then return.
